Cerevel Therapeutics Holdings Inc - Results From Tavapadon Phase 3 Monotherapy Trials (Tempo-1 and Tempo-2) Are Expected in Second Half of 2024
Cerevel Therapeutics Holdings Inc——Tavapadon 三期单一疗法试验(Tempo-1 和 Tempo-2)的结果预计将于 2024 年下半年公布
Cerevel Therapeutics Holdings Inc - Results From Tavapadon Phase 3 Monotherapy Trials (Tempo-1 and Tempo-2) Are Expected in Second Half of 2024
Cerevel Therapeutics Holdings Inc——Tavapadon 三期单一疗法试验(Tempo-1 和 Tempo-2)的结果预计将于 2024 年下半年公布
使用浏览器的分享功能,分享给你的好友吧